INNV · InnovAge Holding Corp.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $30.5M | Three months ended March 31, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net loss -29.94M
+988K Interest expense, net
-294K Other investment income
+4.82M Depreciation and amortization
+167K Provision for income tax
+1.79M Stock-based compensation
+51.86M Litigation costs and settlement
+0K M&A diligence, transaction and integration
+1.1M Business optimization
+0K Impairments and loss on assets held for sale
= Adjusted EBITDA 30.5M
|
|||
| Adjusted EBITDA margin non-GAAP | 12.1% | Three Months Ended March 31, 2026 | — |
|
|
|||
| Census | 8,050 | Three Months Ended March 31, 2026 | — |
|
|
|||
| Center-Level Contribution Margin | $61.02M | Three Months Ended March 31, 2026 | — |
| Center-level Contribution Margin as a percent of revenue non-GAAP | 24.2% | Three Months Ended March 31, 2026 | — |
| Loss Before Income Taxes as a percent of revenue | -11.8% | Three Months Ended March 31, 2026 | — |
| Net income (loss) margin | -11.9% | Three months ended March 31, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
INNV
this stock
InnovAge Holding Corp.
|
$1.49B | +111.2% | +11.8% | — | 0.6% |
|
HCA
HCA Healthcare, Inc.
|
$95.21B | -8.1% | +7.1% | 14.8 | 2.7% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$30.73B | -4.8% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$22.61B | +41.3% | +0.9% | 10.8 | 4.0% |
|
FMS
Fresenius Medical Care AG
|
$12.47B | -1.6% | +5.9% | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| INNV | +3.3% | -5.2% | +18.2% | -3.5% | +111.2% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | +4.7% | -8.8% | +6.7% | -6.0% | +98.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.